{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:46:19Z","timestamp":1755218779079,"version":"3.43.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.canrad.2025.104646","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:42:42Z","timestamp":1749876162000},"page":"104646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["First case report of radiation-recall myositis following trabectedin in patient with stage IV mesenchymal chondrosarcoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Chiara","family":"Casale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pierre","family":"Sunyach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2750-0326","authenticated-orcid":false,"given":"Camille","family":"Roukoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2025.104646_bib0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1148\/73.2.175","article-title":"Potentiation of x-ray effects by actinomycin D","volume":"73","author":"D\u2019Angio","year":"1959","journal-title":"Radiology"},{"key":"10.1016\/j.canrad.2025.104646_bib0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(01)00328-0","article-title":"Characterizing the phenomenon of radiation recall dermatitis","volume":"59","author":"Camidge","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104646_bib0120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ctrv.2005.07.008","article-title":"Radiation recall: a well recognized but neglected phenomenon","volume":"31","author":"Azria","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canrad.2025.104646_bib0125","doi-asserted-by":"crossref","first-page":"103527","DOI":"10.1016\/j.critrevonc.2021.103527","article-title":"Radiation recall reactions: an oncologic enigma","volume":"168","author":"McKay","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.canrad.2025.104646_bib0130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4103\/0973-1482.146090","article-title":"Radiation recall phenomenon presenting as myositis triggered by carboplatin plus paclitaxel and related literature review","volume":"10","author":"Maeng","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.canrad.2025.104646_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1278-3218(01)00142-1","article-title":"[Mature bone radionecrosis: from recent physiopathological knowledge to an innovative therapeutic action]","volume":"6","author":"Delanian","year":"2002","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104646_bib0140","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/hed.20121","article-title":"Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial","volume":"27","author":"Delanian","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2025.104646_bib0145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.canrad.2025.104646_bib0150","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/10781552221125869","article-title":"Radiation recall myositis with pazopanib in a patient with soft tissue sarcoma","volume":"29","author":"Varan","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.canrad.2025.104646_bib0155","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1634\/theoncologist.2009-0090","article-title":"Radiation recall with anticancer agents","volume":"15","author":"Burris","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.canrad.2025.104646_bib0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00256-014-1996-1","article-title":"Gemcitabine-induced radiation recall myositis","volume":"44","author":"Delavan","year":"2015","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.canrad.2025.104646_bib0165","doi-asserted-by":"crossref","first-page":"e240896","DOI":"10.1136\/bcr-2020-240896","article-title":"Paraspinal radiation recall myositis after gemcitabine for pancreatic adenocarcinoma","volume":"14","author":"Barrios-Anderson","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.canrad.2025.104646_bib0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.prro.2014.03.009","article-title":"Radiation recall myositis: two sites, one patient","volume":"5","author":"Grover","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104646_bib0175","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/md13020974","article-title":"Trabectedin in soft tissue sarcomas","volume":"13","author":"Petek","year":"2015","journal-title":"Mar Drugs"},{"key":"10.1016\/j.canrad.2025.104646_bib0180","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1091\/mbc.e08-02-0215","article-title":"Transcription-coupled DNA double-strand breaks are mediated via the nucleotide excision repair and the Mre11-Rad50-Nbs1 complex","volume":"19","author":"Guirouilh-Barbat","year":"2008","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.canrad.2025.104646_bib0185","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/bjc.2014.149","article-title":"Trabectedin, a drug acting on both cancer cells and the tumour microenvironment","volume":"111","author":"D\u2019Incalci","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2025.104646_bib0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1470-2045(15)70098-7","article-title":"Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study","volume":"16","author":"Kawai","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104646_bib0195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejca.2015.12.014","article-title":"Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy","volume":"56","author":"Araki","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2025.104646_bib0200","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.lungcan.2006.06.021","article-title":"Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis","volume":"54","author":"Barl\u00e9si","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2025.104646_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000365918","article-title":"Vemurafenib-induced radiation recall dermatitis: case report and review of the literature","volume":"230","author":"Conen","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.canrad.2025.104646_bib0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3892\/ol.2010.195","article-title":"Radiation recall dermatitis due to gemcitabine does not suggest the need to discontinue chemotherapy","volume":"2","author":"Lock","year":"2011","journal-title":"Oncol Lett"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:47:41Z","timestamp":1754480861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825000629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1278321825000629"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104646","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First case report of radiation-recall myositis following trabectedin in patient with stage IV mesenchymal chondrosarcoma","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104646"}}